These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
196 related articles for article (PubMed ID: 22382641)
1. Correlation of serum Anti-Müllerian hormone concentrations on day 3 of the in vitro fertilization stimulation cycle with assisted reproduction outcome in polycystic ovary syndrome patients. Xi W; Gong F; Lu G J Assist Reprod Genet; 2012 May; 29(5):397-402. PubMed ID: 22382641 [TBL] [Abstract][Full Text] [Related]
2. [Value of anti-Müllerian hormone in predicting pregnant outcomes of polycystic ovary syndrome patients undergone assisted reproductive technology]. Li Y; Tan JQ; Mai ZY; Yang DZ Zhonghua Fu Chan Ke Za Zhi; 2018 Jan; 53(1):23-30. PubMed ID: 29374882 [No Abstract] [Full Text] [Related]
3. Anti-Müllerian hormone levels to predict oocyte maturity and embryo quality during controlled ovarian hyperstimulation. Melado Vidales L; Fernández-Nistal A; Martínez Fernández V; Verdú Merino V; Bruna Catalán I; Bajo Arenas JM Minerva Ginecol; 2017 Jun; 69(3):225-232. PubMed ID: 27352270 [TBL] [Abstract][Full Text] [Related]
4. High serum Antimullerian hormone levels are associated with lower live birth rates in women with polycystic ovarian syndrome undergoing assisted reproductive technology. Tal R; Seifer CM; Khanimov M; Seifer DB; Tal O Reprod Biol Endocrinol; 2020 Mar; 18(1):20. PubMed ID: 32156287 [TBL] [Abstract][Full Text] [Related]
5. Anti-Müllerian hormone serum values and ovarian reserve: can it predict a decrease in fertility after ovarian stimulation by ART cycles? Patrelli TS; Gizzo S; Sianesi N; Levati L; Pezzuto A; Ferrari B; Bacchi Modena A PLoS One; 2012; 7(9):e44571. PubMed ID: 22984527 [TBL] [Abstract][Full Text] [Related]
6. Anti-mullerian hormone as a predictive factor in assisted reproductive technique of polycystic ovary syndrome patients. Aleyasin A; Aghahoseini M; Mokhtar S; Fallahi P Acta Med Iran; 2011; 49(11):715-20. PubMed ID: 22131240 [TBL] [Abstract][Full Text] [Related]
7. Relationship Between Anti-Müllerian Hormone and Sun XY; Lan YZ; Liu S; Long XP; Mao XG; Liu L Front Endocrinol (Lausanne); 2020; 11():595448. PubMed ID: 33343511 [TBL] [Abstract][Full Text] [Related]
8. Anti-Mullerian hormone is a better marker than inhibin B, follicle stimulating hormone, estradiol or antral follicle count in predicting the outcome of in vitro fertilization. Kunt C; Ozaksit G; Keskin Kurt R; Cakir Gungor AN; Kanat-Pektas M; Kilic S; Dede A Arch Gynecol Obstet; 2011 Jun; 283(6):1415-21. PubMed ID: 21562964 [TBL] [Abstract][Full Text] [Related]
9. Anti-Müllerian hormone dynamics during GNRH-antagonist short protocol for IVF/ICSI in women with varying ovarian reserve levels. Melado Vidales L; Fernández-Nistal A; Martínez Fernández V; Verdú Merino V; Bruna Catalán I; Bajo Arenas JM Minerva Ginecol; 2017 Apr; 69(2):128-134. PubMed ID: 27310675 [TBL] [Abstract][Full Text] [Related]
10. High Serum Anti-Müllerian Hormone Concentrations Are Associated With Poor Pregnancy Outcome in Fresh IVF/ICSI Cycle but Not Cumulative Live Birth Rate in PCOS Patients. Guo Y; Liu S; Hu S; Li F; Jin L Front Endocrinol (Lausanne); 2021; 12():673284. PubMed ID: 34122349 [TBL] [Abstract][Full Text] [Related]
11. Anti-Müllerian hormone versus antral follicle count for defining the starting dose of FSH. Lan VT; Linh NK; Tuong HM; Wong PC; Howles CM Reprod Biomed Online; 2013 Oct; 27(4):390-9. PubMed ID: 23953069 [TBL] [Abstract][Full Text] [Related]
12. [Serum levels of anti-muller hormone in women with polycystic ovary syndrome and healthy women of reproductive age]. Parahuleva N; Pehlivanov B; Orbecova M; Deneva T; Uchikova E Akush Ginekol (Sofiia); 2013; 52 Suppl 1():16-23. PubMed ID: 24294740 [TBL] [Abstract][Full Text] [Related]
13. High anti-Müllerian hormone levels might not reflect the likelihood of clinical pregnancy rate in IVF/ICSI treatment. Sun TC; Zhou SJ; Song LL; Li JH; Chen X; Tian L JBRA Assist Reprod; 2021 Apr; 25(2):266-271. PubMed ID: 33710839 [TBL] [Abstract][Full Text] [Related]
14. The dynamics of serum anti-Mullerian-hormone levels during controlled ovarian hyperstimulation with GnRH-antagonist short protocol in polycystic ovary syndrome and low responders. Weintraub A; Margalioth EJ; Chetrit AB; Gal M; Goldberg D; Alerhand S; Eldar-Geva T Eur J Obstet Gynecol Reprod Biol; 2014 May; 176():163-7. PubMed ID: 24630573 [TBL] [Abstract][Full Text] [Related]
15. Clinical value of serum anti-mullerian hormone and inhibin B in prediction of ovarian response in patients with polycystic ovary syndrome. Zhang F; Liu XL; Rong N; Huang XW J Huazhong Univ Sci Technolog Med Sci; 2017 Feb; 37(1):70-73. PubMed ID: 28224431 [TBL] [Abstract][Full Text] [Related]
16. Differential response of AMH to GnRH agonist among individuals: the effect on ovarian stimulation outcomes. Cai J; Liu L; Zheng J; Zhang L; Jiang X; Li P; Sha A; Ren J J Assist Reprod Genet; 2018 Mar; 35(3):467-473. PubMed ID: 29264688 [TBL] [Abstract][Full Text] [Related]
17. Anti-Müllerian hormone: correlation of early follicular, ovulatory and midluteal levels with ovarian response and cycle outcome in intracytoplasmic sperm injection patients. Elgindy EA; El-Haieg DO; El-Sebaey A Fertil Steril; 2008 Jun; 89(6):1670-6. PubMed ID: 17658520 [TBL] [Abstract][Full Text] [Related]
18. The use of anti-Müllerian hormone and antral follicle count to predict the potential of oocytes and embryos. Majumder K; Gelbaya TA; Laing I; Nardo LG Eur J Obstet Gynecol Reprod Biol; 2010 Jun; 150(2):166-70. PubMed ID: 20223579 [TBL] [Abstract][Full Text] [Related]
19. Outcomes of anti-Müllerian hormone-tailored ovarian stimulation protocols in in vitro fertilization/intracytoplasmic sperm injection cycles in women of advanced age. Liao CC; Lee RK; Lin SY; Lin MH; Hwu YM Taiwan J Obstet Gynecol; 2016 Apr; 55(2):239-43. PubMed ID: 27125408 [TBL] [Abstract][Full Text] [Related]
20. Predictive value of anti-Mullerian hormone for pregnancy outcomes following assisted reproductive techniques (ART) in Southwest China. Liu L; Sun XY; Yang H; Feng XJ; Lan YZ Reprod Health; 2022 Dec; 19(1):224. PubMed ID: 36514055 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]